Trial to Increase FEP Attendance

First-Episode Psychosis Clinical Trial

Official title: Financial Incentives to Increase Treatment Attendance in First-Episode Psychosis Care: A Non-Randomized, Adaptive Pilot Study

Status Not yet recruiting

Clinical Trial Summary

Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• First-Episode Psychosis
• Mental Disorders
• Psychotic Disorders

• NCT number: NCT05967195
• Study type: Interventional
• Source: University of Pennsylvania
• Contact: Willam R Smith, MD, PhD
• Phone: 215-898-7366
• Email: wrsmith5@gmail.com
• Status: Not yet recruiting
• Phase: Early Phase 1
• Start date: June 2024
• Completion date: June 2025